The "buyout" seems to always be near, but remains elusive. I would like one buyout prediction to finally come to pass. Happy to see anything above 18 or 20 at this point. Can't leave, but would like to move on with some newly added capital. Dog.
Thanks Flex. I really think Denner is very motivated to sell the company sooner vs later and minimize any further risk as anything can potentially go wrong (when it comes to biotech). If he can secure a high 20s bid I think he'll convince the large institutional holders that he should accept!
A win-win today, in the current environment and potential uncertainty in 2017, is a GOOD thing!
News 
Market Data 
Discover 
AI
